These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 11865062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A.
    Nature; 1998 May 28; 393(6683):386-9. PubMed ID: 9620804
    [Abstract] [Full Text] [Related]

  • 10. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
    David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson WG.
    Cancer Biol Ther; 2004 Jun 28; 3(6):540-8. PubMed ID: 15034303
    [Abstract] [Full Text] [Related]

  • 11. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT, Gonzales FA, Jones PA.
    Nucleic Acids Res; 2001 Nov 15; 29(22):4598-606. PubMed ID: 11713309
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE, Bachman KE, Myöhänen S, Herman JG, Baylin SB.
    Nat Genet; 1999 Jan 15; 21(1):103-7. PubMed ID: 9916800
    [Abstract] [Full Text] [Related]

  • 15. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin.
    El-Osta A, Baker EK, Wolffe AP.
    Mol Biol Rep; 2001 Jan 15; 28(4):209-15. PubMed ID: 12153140
    [Abstract] [Full Text] [Related]

  • 16. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG, Jiang CL, Rauch T, Li H, Pfeifer GP.
    J Biol Chem; 2005 Apr 01; 280(13):12700-9. PubMed ID: 15701600
    [Abstract] [Full Text] [Related]

  • 17. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar 01; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

  • 18. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF, Zhu XJ, Peng G, Dai DQ.
    Oncol Rep; 2009 Nov 01; 22(5):1221-7. PubMed ID: 19787243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.